Updated: Failed study, dimmed hopes in hunt for Alzheimer’s treatment

INDIANAPOLIS — A treatment for Alzheimer’s failed to slow mental decline in a widely anticipated study, ending hope that researchers at Eli Lilly had finally found a drug that does more to help those suffering from the fatal, mind-robbing disease. The pharmaceutical company’s shares plunged Wednesday before markets opened. The drug, solanezumab, missed the study’s […]